Holen Sie sich die Stockscreener-App
6.005
1.15%
-0.075
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Idahoans may be eligible for money from generic drug settlement - KMVT
Idaho joins $17.85M settlement over alleged generic drug price-fixing - KTVB
$17.85 Million in Settlements in Ongoing Generic Drug Price-Fixing Conspiracy Cases - Big Country News
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
Bausch + Lomb CEO: Standing still is the new falling behind - Fortune
10 students living with GI disease to get up to $10K for school - Stock Titan
Bausch Health Cos (BHC) to Release Earnings on Wednesday - MarketBeat
AG settlements with Lannett and Bausch $17M - Oregon Business Report
Future of Ion Channel Modulators Market Growth (2026-2033) | - openPR.com
Scar Treatment Market Expected See Incredible Growth - openPR.com
Is Bausch Health (BHC) Pricing Reflect Long Term Potential After 81% Five Year Share Slump - Sahm
Migraine Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | GSK, Merck, Pfizer, Bausch Health, Amgen, Abbvie AstraZeneca, Eli Lilly and Co - Barchart.com
The Truth About Bausch Health Companies: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS
Lupin’s Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch HealthLupin | Press Release - lupin.com
AG Drummond reaches settlement with drug companies accused of price-fixing - fox23.com
The Bull Case For Bausch Health Companies (BHC) Could Change Following Failed Xifaxan RED-C Trials Learn Why - Yahoo Finance
Wall Street Zen Upgrades Bausch Health Cos (NYSE:BHC) to "Strong-Buy" - MarketBeat
Are you eligible to receive a portion of $17 million pharmaceutical settlement? - FourStatesHomepage.com
Bausch Health (BHC) Announces Global Phase 3 RED-C Clinical Program Results - Finviz
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV) - The Globe and Mail
CT Prescription Buyers Could See Refunds In $17.9M Drug Price-Fixing Settlement - AOL.com
Quarterly Earnings: Is HGBL in a long term uptrendTrade Risk Summary & Real-Time Market Trend Scan - baoquankhu1.vn
Connecticut AG William Tong settles with Lannett and Bausch for nearly $18 million - fox61.com
Michigan AG Secures $17.85M in Settlements with Lannett, Bausch Over Generic Drug Price-Fixing Allegations - Hoodline
Nebraska Attorney General’s Office Announces Settlements with Lannett and Bausch Totaling $17.85 Million Over Conspiracies to Inflate Prices and Limit Competition - chadronradio.com
Maryland Announces $17.85 Million Settlement in Drug Pricing Case - The MoCo Show -
Maryland Attorney General announces $17.85 million settlements with generic drug manufacturers - nottinghammd.com
Analyst Downgrade: Is now the right time to enter ADNT2025 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention - Finviz
Bausch Health Companies Inc. (BHC): Investor Outlook With A 28.97% Potential Upside - DirectorsTalk Interviews
AG Jennings Secures $17.85-million Settlement with Lannett and Bausch; Compensation Possible - WGMD
Attorney General Jeff Jackson Reaches $17.85 Million Settlement with Lannett and Bausch Over Generic Drug Price Fixing; Sues Novartis and Sandoz - NCDOJ (.gov)
How to get compensation after DC, Md. and Va. settle $17.85M drug price fixing lawsuit - WJLA
South Dakota settles with two generic drug companies; Joins lawsuit against a third - DRGNews
Attorneys general across the U.S, including Illinois, reach nearly $18 million drug settlement - cbsnews.com
Lannett and Bausch reach $18M drug price-fixing settlement with states - Crain's New York Business
Colorado and coalition strike a deal with drug companies accused of price-fixing - Colorado Public Radio
Arizona AG announces settlements over generic drug prices - KTAR News 92.3 FM
South Dakota joins settlements totaling $17.85 million over generic drug price fixing - KOTA Territory News
AG Sunday Announces $17.85M National Settlement Over Generic Drug Price-Fixing; Pennsylvanians are Eligible for Compensation - attorneygeneral.gov
Lannett and Bausch Drug Price Fixing Deal Reaches $17.85M Multistate Settlement - USA Herald
South Dakota Attorney General Jackley Announces Settlement With Two Generic Drug Companies - South Dakota State News (.gov)
Bausch, Lannett To Pay $17.9M In Drug Price-Fixing Deal - Law360
Attorney General Tong Announces Settlements With Lannett and Bausch - CT.GOV-Connecticut's Official State Website (.gov)
Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares? - Yahoo Finance
Bausch Health Trial Miss Puts Liver Program And Valuation In Focus - Yahoo Finance
Phase 3 RED-C Miss for Hepatic Encephalopathy Prevention Might Change The Case For Investing In Bausch Health Companies (BHC) - simplywall.st
Institutional Investors May Adopt Severe Steps After Bausch Health Companies Inc.'s (NYSE:BHC) Latest 15% Drop Adds to a Year Losses - 富途牛牛
Earnings Beat: How do insiders feel about Central Plains Bancshares IncPortfolio Performance Summary & Growth Focused Entry Reports - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring A 28% Potential Upside - DirectorsTalk Interviews
Does Bausch Health Companies Inc. have a sustainable dividend2025 Pullback Review & Weekly Top Performers Watchlists - mfd.ru
Can Bausch Health Companies Inc. expand into new marketsJuly 2025 Trends & Smart Money Movement Tracker - mfd.ru
Myopia And Presbyopia Treatment Market Is Going to Boom | ALCON - openPR.com
Trend Recap: Can Bausch Health Companies Inc sustain its profitabilityIndex Update & Weekly Breakout Watchlists - baoquankhu1.vn
Portfolio Shifts: What drives Bausch Health Companies Incs stock priceGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Bausch Health stock unchanged as Phase 3 RED-C trial fails primary endpoint - Investing.com Nigeria
Down 17.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Bausch (BHC) - Finviz
Bausch Health’s new formulation of Xifaxan fails pair of Phase III trials - Yahoo Finance
Bausch Health's brain dysfunction treatment fails late-stage trials - Reuters
Nasdaq Moves: Can Bausch Health Companies Inc beat the S P 5002025 Trade Ideas & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
0.07%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):